Daniel Perkins

Adjunct Associate Professor at Swinburne University of Technology

Daniel Perkins serves as the CEO of Neurala Biosciences since February 2022. Additionally, Daniel holds the position of Head of the Psychedelics Research and Therapeutics Unit at the University of Melbourne since June 2016. As an Adjunct Associate Professor at Swinburne University of Technology and Executive Director at the Psychae Institute, both roles have been fulfilled since June 2021. Previously, Daniel was the Director of the Office of Medicinal Cannabis at the Department of Health and Human Services.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices